Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat

A specific RNA sequence located in the leader of all human immunodeficiency virus type 1 (HIV-1) mRNAs termed the transactivation response element, or TAR, is a primary target for induction of HIV-1 long terminal repeat activity by the HIV-1-derived trans-regulatory protein, Tat. Human neurotropic virus, JC virus (JCV), a causative agent of the degenerative demyelinating disease progressive multifocal leukoencephalopathy, contains sequences in the 5' end of the late RNA species with an extensive homology to HIV-1 TAR. In this study, we examined the possible role of the JCV-derived TAR-homologous sequence in Tat-mediated activation of the JCV late promoter (Tada et al., Proc. Natl. Acad. Sci. USA 87:3479-3483, 1990). Results from site-directed mutagenesis revealed that critical G residues required for the function of HIV-1 TAR that are conserved in the JCV TAR homolog play an important role in Tat activation of the JCV promoter. In addition, in vivo competition studies suggest that shared regulatory components mediate Tat activation of the JCV late and HIV-1 long terminal repeat promoters. Furthermore, we showed that the JCV-derived TAR sequence behaves in the same way as HIV-1 TAR in response to two distinct Tat mutants, one of which that has no ability to bind to HIV-1 TAR and another that lacks transcriptional activity on a responsive promoter. These results suggest that the TAR homolog of the JCV late promoter is responsive to HIV-1 Tat induction and thus may participate in the overall activation of the JCV late promoter mediated by this transactivation.

[1]  H. Mayan,et al.  [AIDS dementia]. , 2020, Harefuah.

[2]  R. Gaynor,et al.  tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. , 1991, Genes & development.

[3]  B Tidor,et al.  Arginine-mediated RNA recognition: the arginine fork , 1991, Science.

[4]  D. Hudson,et al.  Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. , 1991, Genes & development.

[5]  J. Taylor,et al.  Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. , 1990, Oncogene.

[6]  T. Okamoto,et al.  Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro. , 1990, Virology.

[7]  D. Gabuzda Neurologic disorders associated with HIV infections. , 1990, Journal of the American Academy of Dermatology.

[8]  S. Salahuddin,et al.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.

[9]  K. Khalili,et al.  Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Sonenberg,et al.  Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence , 1990, Journal of virology.

[11]  K. Khalili,et al.  The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. , 1989, The New biologist.

[12]  B. Cullen,et al.  Regulatory pathways governing HIV-1 replication , 1989, Cell.

[13]  R. Gaynor,et al.  Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Frumkin AIDS in the Nervous System , 1989 .

[15]  K. Khalili,et al.  Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation , 1989, Journal of virology.

[16]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[17]  M. Ptashne How eukaryotic transcriptional activators work , 1988, Nature.

[18]  R. Gaynor,et al.  Functional domains required for tat‐induced transcriptional activation of the HIV‐1 long terminal repeat. , 1988, The EMBO journal.

[19]  Eric C. Holland,et al.  HIV-1 tat trans-activation requires the loop sequence within tar , 1988, Nature.

[20]  M. Post,et al.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. , 1987, Annals of internal medicine.

[21]  J. Brady,et al.  Spacing between simian virus 40 early transcriptional control sequences is important for regulation of early RNA synthesis and gene expression , 1986, Journal of virology.

[22]  B. Navia,et al.  The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.

[23]  S. Kenney,et al.  Mapping 5' termini of JC virus late RNA , 1986, Journal of virology.

[24]  G. Khoury,et al.  JC virus enhancer-promoter active in human brain cells. , 1984, Science.

[25]  P Gruss,et al.  Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus , 1984, Journal of virology.

[26]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[27]  B. Padgett,et al.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. , 1973, The Journal of infectious diseases.

[28]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[29]  J. Lisziewicz,et al.  Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. , 1991, The New biologist.

[30]  N. Sonenberg,et al.  A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. , 1990, Genes & development.

[31]  M. Smith,et al.  Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. , 1983, Methods in enzymology.